Join our BD Manager, Liz Bailey, at the 8th Annual DDR Inhibitor Summit in Boston, Jan 28-30. Let's connect to discuss how Reaction´s service offering in the DNA Damage space can help your discovery and development programs
#DDR#DrugDevelopment#DNADamage#DDRInhibitors
Curious about groundbreaking ADC solutions? 🌟 Meet CSO Haiching Ma and Sr. Business Dev. Manager Sara Herrmann at the World ADC Conf. in San Diego! Accelerate every ADC discovery phase with us. Don’t miss out! #ADC#Innovation#OncologyDrugDiscovery
Dive into our blog for a detailed comparison of luminescence-based vs radiometric kinase activity assays.
Discover when to use the gold standard radiometric format or if you should prefer ADP-Glo 👉https://t.co/iQP6Fk6sW2
#kinaseactivity#radiometricassay#ADPGlo
Reaction Biology teamed up with @MayoClinic to explore the anti-angiogenic potential of pan-VEGFR tyrosine kinase inhibitors.
📄 Read the study: https://t.co/qAkPUdeVrs
🔬 Discover HotSpot™: https://t.co/zh15C8i0Fn
#angiogenesis#kinaseinhibitor#VEGFR@PLOSBiology
🔬 Exciting News for our Biotech Community! 🎉 We are thrilled to announce the latest addition to our family of kinase assay services - ADP-Glo™! 🌟
🔗 https://t.co/yU2mj173JO
#KinaseAssay#ADPGlo#KinaseDiscovery#preclinicaloncology
🚨 Don't miss out on our enrollment deadline on Sept 13! Join our SubQperior syngeneic screens for superior models, flexibility of choice, and a special offer! Enroll now at: https://t.co/HJsRTzJYUe #immunotherapy#oncology#drugdiscovery#syngeneic
🚀 Get ready for an exciting new launch! We're thrilled to announce the upcoming release of our new Kinase Assay, adding to our top-notch HotSpot radiometric assay. Stay tuned for more updates on this game-changing service! 🧪✨ #Science#Innovation#KinaseAssay
Bridging the gap between in vitro and in vivo data just became simpler. We're proud to introduce you to our In vivo Hollow Fiber Platform! Click on the link below to learn more --> https://t.co/pFrwYdRiZh
#cancerresearch#invivomodelfortumor#oncologydrugdevelopment
Check out our blog for key evidence and tailored solutions for researchers in oncology drug discovery wanting to select optimal cell-based assays to evaluate compound efficacy https://t.co/ianhciISG8 #CellBasedAssays#KinaseInhibitors 🧪🔬🔍
Dive into a summer read on NanoBRET™ and learn how to accurately quantify binding affinity in living cells! Discover more about real-time kinase activity detection here: https://t.co/8ls5wZxqhn 📚🧬💡
#NanoBRET#KinaseInhibitor#CellBasedAssay@promega
Deadline approaching! ⏰ HotSpot Kinase Screen is your key to unlocking kinase insights. Test at physiological ATP levels (1mM) and accelerate your drug discovery program. Sign up by August 7th!
https://t.co/22KGkUFQpg
#kinaseresearch#kinase#cancer#pharma#radiometricassay
Struggling to choose the right kinase assay format? Let us help. In this Technology Spotlight & Applications, we equip you with the knowledge you need to make the smartest choice for your kinase screen. Click on the link below to download the literature:
https://t.co/8J39NLIVlN
⏰ Tick Tock! Don't miss out on our 2D and 3D ProLiFiler™ screen enrollment deadline: Aug 2nd! Evaluate your compound's efficacy in 160 tumor cell lines in 2D or 40 spheroid lines.
https://t.co/hWd0agfUXX
#cancerresearch#deadline#drugdiscovery
Curious about our cutting-edge CAR-T cell therapy platform? Download this Factsheet to discover how our in vitro and in vivo platform can contribute to you success in CAR-T cell therapy development.
https://t.co/YuYqe2nGTR
#CAR-T #CellTherapy#Innovation#CancerTreatment